Nucarnit Tablet contains Levo-carnitine 330 mg, an essential nutrient involved in the transport of long-chain fatty acids into the mitochondria for energy production. It plays a critical role in cellular energy metabolism, particularly in muscle tissues including the heart. Nucarnit is indicated for the treatment of primary and secondary carnitine deficiency, which may result from genetic disorders, chronic diseases, or certain medications. It is also used as an adjunct therapy in conditions such as chronic heart failure, peripheral arterial disease, and muscle weakness associated with aging or metabolic disorders. Levo-carnitine supplementation helps improve exercise capacity, reduce fatigue, and enhance overall muscle function by facilitating fatty acid oxidation and ATP generation. The tablet is typically administered orally, with dosage adjusted according to the patient’s clinical condition and response to therapy. Nucarnit is generally well tolerated; however, mild gastrointestinal disturbances such as nausea, vomiting, or abdominal discomfort may occur. Caution is advised in patients with hypothyroidism or seizure disorders. Regular monitoring of carnitine levels and clinical status is recommended during prolonged therapy. Nucarnit Tablet should be used under medical supervision to ensure optimal therapeutic outcomes and safety.